trial,pubID,pseudogroup,weeks,group,IgD-/IgM-/IgA-/IgG+/Antigen++ B cells
G002,G002-852,G002,8,1,11836.0
G002,G002-616,G002,8,1,16244.0
G002,G002-931,G002,8,3,10607.0
G002,G002-577,G002,8,2,15375.0
G002,G002-493,G002,8,2,7769.0
G002,G002-119,G002,8,2,7415.0
G002,G002-758,G002,8,1,6645.0
G002,G002-831,G002,8,2,11722.0
G002,G002-502,G002,8,1,10268.0
G002,G002-293,G002,8,2,8870.0
G002,G002-943,G002,8,2,10627.0
G002,G002-630,G002,8,2,5817.0
G002,G002-136,G002,8,2,5746.0
G002,G002-341,G002,8,2,7949.0
G002,G002-145,G002,8,2,6828.0
G002,G002-371,G002,8,3,5151.0
G002,G002-820,G002,8,2,6899.0
G002,G002-997,G002,8,3,6148.0
G002,G002-509,G002,8,1,4855.0
G002,G002-813,G002,8,1,3188.0
G002,G002-988,G002,8,3,6686.0
G002,G002-619,G002,8,1,11287.0
G002,G002-905,G002,8,1,5207.0
G002,G002-304,G002,8,3,2735.0
G002,G002-546,G002,8,1,4976.0
G002,G002-855,G002,8,2,6192.0
G002,G002-516,G002,8,1,2725.0
G002,G002-477,G002,8,3,5103.0
G002,G002-678,G002,8,1,3090.0
G002,G002-884,G002,8,3,3277.0
G002,G002-230,G002,8,2,29985.0
G002,G002-796,G002,8,3,9693.0
G002,G002-620,G002,8,2,1986.0
G002,G002-595,G002,8,3,1745.0
G002,G002-866,G002,8,3,1624.0
G002,G002-733,G002,8,1,5658.0
G002,G002-871,G002,8,3,1983.0
G002,G002-834,G002,8,1,4533.0
G002,G002-969,G002,8,1,5574.0
G002,G002-810,G002,8,3,1852.0
G002,G002-427,G002,8,3,954.0
G002,G002-957,G002,8,2,5834.0
G002,G002-479,G002,8,1,5171.0
G002,G002-302,G002,8,1,3089.0
G002,G002-632,G002,8,3,352.0
G002,G002-947,G002,8,2,1002.0
G002,G002-480,G002,8,2,1941.0
G002,G002-462,G002,8,3,253.0
G002,G002-278,G002,8,3,2613.0
